Gene · 27329
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic modifiers of the Portfolio Diet Score and LDL cholesterol in young adults. | Nutr Metab Cardiovasc Dis | 2026 | 42323221 | PubTator, text mining | PubMed |
| The role of lipid-lowering drugs in urologic and male reproductive cancers: a Mendelian randomization study. | Transl Androl Urol | 2026 | 42293830 | PubTator, text mining | PubMed |
| Angiopoietin-like protein 3 complete and partial deficiency markedly accelerates apolipoprotein B48 and B100 metabolism in triglyceride-rich lipoproteins in humans. | J Intern Med | 2026 | 42273920 | PubTator, text mining | PubMed |
| Encouraging a move toward precision geromedicine. | Geromedicine | 2026 | 42266612 | PubTator, text mining | PubMed |
| A quarter-century of progress: innovations in lipid medicine that transformed cardiovascular prevention. | Lancet Diabetes Endocrinol | 2026 | 42259344 | PubTator, text mining | PubMed |
| Frailty phenotype, genetic risk and long-term incident systemic lupus erythematosus risk: Insights from the UK Biobank study integrated with multi-omics analysis. | Clin Med (Lond) | 2026 | 42242571 | PubTator, text mining | PubMed |
| New and Emerging Therapeutic Targets for ApoB-Containing Particles Lowering. | Circ Res | 2026 | 42241517 | PubTator, text mining | PubMed |
| Triglyceride-Rich Lipoprotein Metabolism and Cardiovascular Risk in Diabetes: Bedside to Bench to Bedside. | Circ Res | 2026 | 42241511 | PubTator, text mining | PubMed |
| Translating Lipoprotein Genetics Into New Therapies. | Circ Res | 2026 | 42241509 | PubTator, text mining | PubMed |
| Integrative analyses elucidate transcriptional regulatory functions of risk alleles for metabolic liver disease. | Nat Genet | 2026 | 42230773 | PubTator, text mining | PubMed |
| Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives. | Front Pharmacol | 2026 | 42206171 | PubTator, text mining | PubMed |
| The Molecular Mechanisms of Metformin's Action on Blood Lipid Profile in Diabetic Patients. | Int J Mol Sci | 2026 | 42196612 | PubTator, text mining | PubMed |
| Lipid dysregulation in chronic diseases: systems biology and omics perspectives. | Xenobiotica | 2026 | 42186308 | PubTator, text mining | PubMed |
| Remnant cholesterol - The transition from biomarker to risk factor. | Atherosclerosis | 2026 | 42178199 | PubTator, text mining | PubMed |
| RNA-Targeted Therapeutics for Lipid Metabolic Disorders: From Bench to Bedside. | Research (Wash D C) | 2026 | 42164756 | PubTator, text mining | PubMed |
| Targeting triglycerides for cardiovascular risk reduction. | Intern Emerg Med | 2026 | 42151489 | PubTator, text mining | PubMed |
| Plasma proteome-wide Mendelian randomization reveals multi-ancestry drug targets for gastric cancer. | Front Oncol | 2026 | 42147228 | PubTator, text mining | PubMed |
| Drug targets for lipid modification and risk of type 2 diabetes: a cis-Mendelian randomization study. | Cardiovasc Diabetol | 2026 | 42135799 | PubTator, text mining | PubMed |
| Gene therapy for liver diseases: methods, challenges and opportunities. | J Nanobiotechnology | 2026 | 42116125 | PubTator, text mining | PubMed |
| Lipid lowering in coronary artery disease - not just statins. | Clin Med (Lond) | 2026 | 42107771 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27329/papers?page=3